Skip to content

Neurological and Psychological Effects of Combat-Related Stress

Neurological and Psychological Effects of Combat-Related Stress

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04651192
Enrollment
100
Registered
2020-12-03
Start date
2019-03-01
Completion date
2025-05-01
Last updated
2025-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress Disorder, Posttraumatic, Stress, Psychological

Brief summary

The purpose of this study is to determine what is the neurological and cognitive impact of combat exposure and prolonged stress, in the form of service in the Israeli Defense Forces.

Detailed description

Attention biases in threat processing have been assigned a prominent role in the etiology and maintenance of anxiety disorders. This study aimed to characterize the mental resilience of combat soldiers, and explore the neuro-cognitive impact of prolonged stress, using eye-tracking, MRI and fMRI measurements. Participants will be assessed using questionnaires, cognitive tasks and magnetic imaging at 5 timepoints over the span of 4 years. Outcome measures will be depression, anxiety and post-traumatic scores, as well as dwell time on threat in eye-tracking paradigms tested in previous studies, and blood oxygen level-dependent (BOLD) signals in magnetic resonance imaging (MRI) measurements.

Interventions

OTHERCombat Exposure

Soldiers will be exposed to combat as part of their routine military service. The ROTC students will not be exposed to combat.

Sponsors

Medical Corps, Israel Defense Force
CollaboratorOTHER
Tel Aviv University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to 23 Years
Healthy volunteers
No

Inclusion criteria

* Soldiers in the paratroopers brigade or students in Tel-Aviv University; * A signed consent form; * Hebrew native speakers.

Exclusion criteria

* A diagnosis of a neurological disorder (i.e., epilepsy, brain injury); * Drug or alcohol abuse; * Cannot undergo an MRI scan, due to metal implants or other metallic foreign bodies, claustrophobia, large tattoos or irremovable piercings; * Require glasses with a number greater than 7; * A diagnosis of psychotic or bipolar disorders.

Design outcomes

Primary

MeasureTime frameDescription
Neurological measures - Gray matter volume4 years, from time point 1 to time point 5Gray matter volume, i.e. the density of brain cells in a particular region (outcome to be measured in cm3), to be derived from the MRI scans, and compared between the two groups across the various time points.
Change from baseline - PTSD Checklist for DSM-5 (PCL-5) score4 years, from time point 1 to time point 5PCL is questionnaire assessing posttraumatic stress disorder symptoms. It contains 20 items on a severity scale of 0-4, measuring the existence and severity of post-traumatic symptoms. The minimal score, indicating no post-traumatic stress, is 0. The maximal score is 80, indicating extremely severe post-traumatic stress.
Neurological measures - Functional connectivity4 years, from time point 1 to time point 5Functional connectivity, indicating the level of synchronous activity of certain brain regions during rest (temporal correlation is usually expressed as a Pearson's r); Also to be derived from the MRI scans, and compared between the two groups across the various time points.
Neurological measures - Structural connectivity4 years, from time point 1 to time point 5Structural connectivity between regions of the brain (Diffusivity is measured as 10-3mm2.s-1) and the properties of the white matter (expressed with Diffusion tensor imaging (DTI) measures, mainly Fractional Anisotropy (FA) and Mean Diffusivity (MD)); Also be derived from the MRI scans, and compared between the two groups across the various time points.
Neurological measures - Task activations4 years, from time point 1 to time point 5Task activations, and specifically the areas activated during the dot-probe task, and how they change over time (expressed as the level of the BOLD signal strength change during the task). To be derived from the MRI scans, and compared between the two groups across the various time points.

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 4, 2026